Zeltiq Aesthetics Inc  

(Public, NASDAQ:ZLTQ)   Watch this stock  
Find more results for Zeltiq Aesthetics Inc�
26.65
+0.73 (2.82%)
After Hours: 25.92 -0.73 (-2.74%)
Oct 30, 5:10PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 25.05 - 26.92
52 week 9.50 - 27.04
Open 25.89
Vol / Avg. 1.08M/624,699.00
Mkt cap 981.19M
P/E     -
Div/yield     -
EPS -0.16
Shares 37.85M
Beta     -
Inst. own 99%
Nov 20, 2014
ZELTIQ Aesthetics Inc at Goldman Sachs US Emerging / SMID Cap Growth Conference - 3:40PM EST - Add to calendar
Nov 20, 2014
ZELTIQ Aesthetics Inc at Canaccord Genuity Medical Technologies & Diagnostics Forum - 11:30AM EST - Add to calendar
Nov 19, 2014
ZELTIQ Aesthetics Inc at Stifel Healthcare Conference - 10:55AM EST - Add to calendar
Nov 3, 2014
ZELTIQ Aesthetics Inc at Barclays Select Series 2014: MedTech SMID Cap Day Add to calendar
Oct 28, 2014
Q3 2014 ZELTIQ Aesthetics Inc Earnings Call
Oct 28, 2014
Q3 2014 ZELTIQ Aesthetics Inc Earnings Release
Sep 18, 2014
ZELTIQ Aesthetics Inc Investor Day
Sep 18, 2014
ZELTIQ Aesthetics Inc at Maxim Group Aesthetics Dinner
Aug 13, 2014
ZELTIQ Aesthetics Inc at Canaccord Genuity Growth Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 10.47% -17.29%
Operating margin 10.87% -17.33%
EBITD margin - -15.78%
Return on average assets 21.03% -21.65%
Return on average equity 29.61% -28.57%
Employees 297 -
CDP Score - -

Address

Suite 100, 4698 Willow Road
PLEASANTON, CA 94588
United States - Map
+1-925-4742500 (Phone)
+1-925-4742599 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Zeltiq Aesthetics, Inc. operates as a medical device development company. It engages in the design, development, and commercialization of non-invasive procedures for the reduction of unwanted fat tissue. It develops Cryolipolysis, a technology that enables the reduction of fat tissue near nerves, muscle, and bones. The Company develops a non-invasive technology for aesthetic applications and plastic surgery. Its product is used as a skin cooling device to minimize pain and thermal injury during laser and dermatological treatments.

Officers and directors

Mark J. Foley President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Patrick Williams Chief Financial Officer, Senior Vice President
Age: 41
Bio & Compensation  - Reuters
Sergio Garcia-Rodriguez Senior Vice President, General Counsel and Corporate Secretary
Age: 52
Bio & Compensation  - Reuters
Keith Sullivan Senior Vice President of Worldwide Sales
Age: 56
Bio & Compensation  - Reuters
Len DeBenedictis Chief Technology Officer
Age: 73
Bio & Compensation  - Reuters
Carl Lamm Vice President of Operations
Age: 52
Bio & Compensation  - Reuters
Mary M. Fisher Director
Age: 52
Bio & Compensation  - Reuters
D. Keith Grossman Director
Age: 54
Bio & Compensation  - Reuters
Jean M. George Independent Director
Age: 56
Bio & Compensation  - Reuters
Kevin C. O'Boyle CPA Independent Director
Age: 58
Bio & Compensation  - Reuters